123i impy
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2006 (NCT00287248)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 123-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- 123i impy
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00287248 | Phase 1 | Feb 1, 2006 | Alzheimer's Association, Institute for Neurodegenerative Disorders, Molecular NeuroImaging |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alzheimer's Association | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Institute for Neurodegenerative Disorders | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Molecular NeuroImaging | For profit | 1 | 0 | 1 | 2006 |
3 organizations
Page 1 / 1